Abstract
MetLife, Inc. will report second-quarter 2026 financial results on August 5, 2026 Post Market, with consensus pointing to revenue of 19.71 billion US dollars and adjusted EPS of 2.29, as investors watch guidance execution on variable investment income and currency translation tailwinds.Market Forecast
Consensus for the current quarter anticipates revenue of 19.71 billion US dollars, up 6.34% year over year, adjusted EPS of 2.29, up 6.77% year over year, and EBIT of 2.20 billion US dollars, up 23.88% year over year. No formal guidance was provided for quarterly gross profit margin or net profit margin, so margin forecasts are omitted. The company’s operating mix last quarter was led by premiums of 12.12 billion US dollars and net investment income of 5.36 billion US dollars, and management has guided pre-tax variable investment income of 220.00–270.00 million US dollars for the quarter with a full-year target of 1.60 billion US dollars. The most promising near-term earnings driver appears to be investment-related income, with net investment income at 5.36 billion US dollars last quarter and company guidance indicating supportive conditions for variable investment income; year-over-year segment growth was not disclosed in the quarterly breakdown.Last Quarter Review
MetLife, Inc. delivered revenue of 19.68 billion US dollars, up 4.54% year over year, a gross profit margin of 28.44%, GAAP net profit attributable to common shareholders of 1.19 billion US dollars, a net profit margin of 6.21%, and adjusted EPS of 2.42, up 23.47% year over year. Adjusted EPS of 2.42 exceeded the 2.27 consensus, and EBIT of 2.15 billion US dollars topped the 1.99 billion US dollars expectation, aided by constructive investment returns and expense discipline. The revenue mix was anchored by premiums at 12.12 billion US dollars, net investment income at 5.36 billion US dollars, and policy fees on universal life and investment-type products at 1.34 billion US dollars, while total company revenue increased 4.54% year over year.Current Quarter Outlook
Premiums and Fee Income
Premiums were the largest revenue line last quarter at 12.12 billion US dollars, and near-term run-rate indicators suggest resilient contributions from protection and group benefits. Within the current quarter, fee income tied to universal life and investment-type products, which totaled 1.34 billion US dollars last quarter, should remain steady given the stickiness of in-force blocks and ongoing policyholder activity. Management commentary and sell-side previews also highlight currency translation as a supportive factor this quarter, with noted appreciation in the Brazilian real and Mexican peso likely to provide a lift to reported international premiums and fees when translated into US dollars. While the company has not issued granular quarter-specific guidance for premium volume, the prior-quarter revenue trajectory and stable policy fee base frame a constructive backdrop for topline stability. The cadence of sales and persistency updates on the call will help investors understand how premium trends are tracking into the second half of 2026.Investment Income and Portfolio Returns
The fulcrum for this quarter’s upside or downside versus expectations is investment-related income. MetLife, Inc. guided pre-tax variable investment income of 220.00–270.00 million US dollars for the quarter and reaffirmed a full-year 2026 target of 1.60 billion US dollars; combined with first-quarter results, the run-rate through the first half was framed in market commentary as reaching roughly 46%–49% of the full-year objective. Last quarter’s net investment income was 5.36 billion US dollars, and first-quarter outperformance benefitted from improved private markets marks, which, if sustained at a moderated pace, can support year-over-year EBIT growth, in line with the 23.88% year-over-year EBIT increase embedded in consensus for this quarter. The breadth of investment drivers includes alternative assets, credit spreads, and equity markets, all of which can influence fair-value marks and variable investment income; while marks introduce some quarter-to-quarter variability, the company’s stated range offers a benchmark to measure actuals against on August 5, 2026. Execution versus that 220.00–270.00 million US dollars range will be the central swing factor for earnings per share relative to the 2.29 forecast.Stock Price Sensitivities This Quarter
Investors are likely to focus on three real-time swing factors: delivery versus the variable investment income range, currency translation impacts in key international markets, and underwriting outcomes. First, a print at or above the top end of the 220.00–270.00 million US dollars variable investment income range would support the 2.29 adjusted EPS consensus and the 2.20 billion US dollars EBIT consensus, while a shortfall could cap upside despite healthy core premiums. Second, as several analysts noted, the quarter benefited from appreciation in the Brazilian real and Mexican peso, which should support reported results; the degree of that currency tailwind may be reflected in reported international premiums and fee income. Third, underwriting outcomes—especially mortality and morbidity experience in the protection lines—and hedging impacts will shape the reported net profit margin outcome, even though there is no margin-specific guidance; in last quarter’s results, net profit margin stood at 6.21%, and any deviation this quarter will likely be tied to a combination of underwriting experience and investment outcomes. Capital deployment remains a secondary support, with the company maintaining its quarterly dividend of 0.5925 US dollars per share (payable September 8, 2026 to holders of record on August 4, 2026), and investors will listen for updates on buyback capacity and capital ratios, which can influence valuation resilience through the balance of 2026.Analyst Opinions
Bullish vs bearish ratio: 10:0. The prevailing view among major institutions is positive, reflected in a consistent cadence of Buy/Overweight ratings and target-price increases in recent weeks. Jefferies reaffirmed a Buy and lifted or reiterated a 103.00 US dollars price target, citing a favorable setup into the quarter and supportive investment income dynamics; UBS also maintained a Buy with a 105.00 US dollars target, indicating confidence in earnings durability across investment and underwriting lines. J.P. Morgan’s Jimmy Bhullar maintained a Buy with a 91.00 US dollars target earlier in the period, and subsequent moves by Morgan Stanley to raise its target to 103.00 US dollars emphasized an expectation that MetLife, Inc. should benefit from the appreciation of the Brazilian real and Mexican peso during the quarter, underscoring FX as a near-term tailwind for reported international results. Additional positive stances came from Wells Fargo (target to 101.00 US dollars), BofA Securities (target to 103.00 US dollars, Buy), Argus (Buy, 93.00 US dollars), and KBW (target to 98.00 US dollars), while Barclays flagged an Overweight view with a 94.00 US dollars target; neutral voices, including Piper Sandler’s unchanged stance, remained in the minority and do not alter the overall bullish skew.The common bullish thread centers on three pillars: execution against the variable investment income range, steady premiums and fee-based income, and favorable currency translation. Analysts view the 220.00–270.00 million US dollars pre-tax variable investment income range as attainable given first-half progression, and they see scope for upside if alternative asset marks remain constructive. On the core operations side, the premium base at 12.12 billion US dollars last quarter and policy fees of 1.34 billion US dollars provide ballast, supporting revenue stability even as investment marks fluctuate quarter to quarter. The FX backdrop—especially in Latin America—was repeatedly cited as a supportive factor for the quarter now being reported, with the view that translation gains augment both revenue and earnings leverage at the margin. Tactically, several houses also highlight that last quarter’s adjusted EPS of 2.42 beat estimates and that EBIT of 2.15 billion US dollars surpassed consensus, setting a constructive precedent heading into this print. The bullish majority expects the company to at least meet the 19.71 billion US dollars revenue and 2.29 adjusted EPS benchmarks, with the potential for modest upside if variable investment income trends toward the upper half of the guided range and FX tailwinds materialize as anticipated.